Molecular evidence for central nervous system involvement in children with newly diagnosed acute lymphoblastic leukemia
โ Scribed by D. A. Januszkiewicz; J. S. Nowak
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 390 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0278-0232
No coin nor oath required. For personal study only.
โฆ Synopsis
Central nervous system (CNS) involvement in children with newly diagnosed acute lymphoblastic leukemia (ALL) would have profound implication for the prognosis and accurate stratification of CNS prophylactic therapy. Using PCR technique with specific primers for V, D and J segments of TCRD gene, the pattern of TCRD gene rearrangements in bone marrow lymphoblasts and in cells from cerebrospinal fluid (CSF) have been investigated. The study involved 21 children at the time of diagnosis with B-lineage ALL. In nine of 21 patients incomplete TCRDVD gene rearrangement has been found in CSF cells, which was identical to that observed in bone marrow of the same children. It can be concluded that at least in 43 per cent of all analysed cases, there were signs of CNS involvement in newly diagnosed ALL patients.
๐ SIMILAR VOLUMES
## Background. We assessed efficacy and morbidity of chemotherapy and 1,800 cGy of hypofractionated craniospinal irradiation (CSI) in children with central nervous system (CNS) relapse following first remisssion of acute lymphoblastic leukemia (ALL). Procedure. Nineteen patients with isolated CNS r
## Abstract Recurrence of acute lymphoblastic leukemia (ALL) in the central nervous system (CNS) confers a poor prognosis, although to the authors' knowledge, only a few studies have analyzed this issue in adults. For the current study, the authors analyzed the frequency, predictive factors, and pr
BACKGROUND. Preventive cranial radiotherapy (CRT) in childhood acute lymphoblastic leukemia (ALL), although effective, may be associated with neurologic sequelae and second malignancies. Attempts to replace CRT with intensified intrathecal therapy (IT) have shown promise in lower risk subgroups. In